ktra stock discussion

Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. DPLS 0.02 0.00 (1.84%) 14,698. With Kintara Therapeutics stock trading at $1.74 per share, the total value of Kintara Therapeutics stock (market capitalization) is $53.29M. F. 1.39. Kintara's VAL-083 is a "first-in-class," small-molecule bifunctional alkylating agent that crosses the blood-brain barrier. Meme Saturday. Kintara Therapeutics has generated ($0.77) earnings per share over the last year. Advisors. DPLS Darkpulse Inc — Stock Price and Discussion | Stocktwits. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. The reported ($0.23) earnings per share for the quarter, missing analysts' consensus estimates of ($0.18) by $0.05. Kintara Therapeutics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. The Opinions takes up to 5 years' worth of historical data and runs these prices through thirteen different technical indicators. Created with Highstock 6.2.0. Board of Directors. View the latest Kintara Therapeutics Inc. (KTRA) stock price, news, historical charts, analyst ratings and financial information from WSJ. KTRA Bullish Setup. Kintara Therapeutics Inc () Stock Market info Recommendations: Buy or sell Kintara Therapeutics stock? ... View entire discussion ( 0 comments) More posts from the pennystocks community. Management Team. Posted by 5 days ago. Darkpulse Inc 0.02 0.00 (1.84%) Darkpulse Inc OTC Updated May 7, 2021 12:58 PM. Given the $4.33 average price target, shares could soar 218% from current levels. Kintara is … KTRA Kintara Therapeutics — Stock Price and Discussion | Stocktwits. Share your opinion and gain insight from other stock traders and investors. Kintara Therapeutics, Inc. Stock Price, News and Company Updates. Barchart Opinions show traders what a variety of popular trading systems are suggesting in terms of going long or short the market. Short term MAs are crossing the longer term MAs and the MACD is rising. For the fiscal year ending Jun 2021 , the consensus EPS* forecast has remained the same over the past week at -0.68 and increased over the past month from -0.69 to -0.68 (1.45%). Long. View which stocks have been most impacted by COVID-19. View the latest KTRA stock quote and chart on MSN Money. From what I can find KTRA is one of the better plays right now. Kintara Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Kintara Therapeutics last announced its earnings data on May 14th, 2021. NASDAQ 0.29%. Kintara Therapeutics, Inc. Common Stock, also called Kintara Therapeutics, is a clinical and biopharmaceutical company, which focuses on the development and … KTRA, Kintara Therapeutics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines KTRA closed down 11.46 percent on Friday, April 16, 2021, on 40 percent of normal volume. Find real-time KTRA - Kintara Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Cumulative Growth of a $10,000 Investment in Stock Advisor Calculated by Time-Weighted Return In-depth view of key statistics and finances for TELLURIAN INC. (TELL) on MSN Money. Kintara Therapeutics 1.79 0.04 (2.29%) Kintara Therapeutics NASDAQ Updated Jun 11, 2021 4:50 PM. During every meal I say “one of you will betray me” in case I die after and want some awkward fun at my funeral. KTRA Stock Chart. 2.0k. Find the latest Kintara Therapeutics, Inc. (KTRA) stock discussion in Yahoo Finance's forum. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2020. Kintara Therapeutics, Inc. was founded in 2009 and is headquartered in San Diego, California. Gainers Ovid Therapeutics (NASDAQ:OVID) stock increased by 74.99% to $5.18 during Wednesday's pre-market session. (See KTRA stock … Free forex prices, toplists, indices and lots more. NASDAQ:KTRA VS S&P 500 (SPY) The Motley Fool. Message Board Total Posts: 21 Are other analysts in agreement? KINTARA THERAPEUTICS, INC. (KTRA) KINTARA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) Most relevant news about KINTARA THERAPEUTICS, INC. KINTARA THERAPEUTICS : Provides Positive Site Activation Update on GCAR Phase 2.. Only Buy ratings, 3 to be exact, have been issued in the last three months. The company has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. When did Kintara Therapeutics' stock split? NASDAQ 0.90%. View KTRA historial stock data and compare to other stocks and exchanges. KTRA Stock Analysis Overview What this means: InvestorsObserver gives Kintara Therapeutics Inc (KTRA) an overall rank of 44, which is below average. KTRA, 1D. DOW 0.03%. Stock has a little bit of a run up the past couple days but is now cooling down. Weedkiller420. Anyone in KTRA? Kintara Therapeutics Inc. (KTRA) Del Mar Pharma is developing new drug candidates targeting orphan cancer indications representing market opportunities in the US$100s of millions in North America and potentially billions of dollars worldwide. Free forex prices, toplists, indices and lots more. (See KTRA stock analysis on TipRanks)DiaMedica Therapeutics (DMAC)Utilizing its cutting-edge technologies, DiaMedica Therapeutics develops novel recombinant proteins to treat kidney and neurological diseases. Trending now. Returns as of 06/12/2021. Since then, KTRA shares have increased by 244.2% and is now trading at $1.79. ... On the penny stock front we need to remember that pennies are overwhelmingly played by retail traders and shady fund managers. SAN DIEGO, May 26, 2021 Kintara Therapeutics (KTRA), Inc., a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that the VAL-083 treatment arm in the Global Coalition for Adaptive Research registrational Phase 2/3 clinical trial for glioblastoma multiforme has … Kintara Therapeutics Inc KTRA 2.29% has announced that the VAL-083 treatment arm in the Global Coalition for Adaptive Research registrational Phase 2/3 … Ideas. Kintara Therapeutics' stock was trading at $0.52 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Kintara Therapeutics stock was originally listed at a price of $68.00 in Feb 22, 2013. SAN DIEGO, June 7, 2021 /PRNewswire/ -- Kintara Therapeutics, Inc. (NASDAQ:KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced Kintara's addition to the Russell Microcap Ò Index. Therefore, the word on the Street is that KTRA is a Strong Buy. Kintara Therapeutics (NASDAQ:KTRA) is currently down 7.64% to a price of $2.46. Located in San Diego, California, Kintara (Nasdaq: KTRA) is dedicated to the development of novel cancer therapies for patients with rare unmet medical needs. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2020. -0.18. KTRA updated stock price target summary. Videos only. Welcome to the Stockopedia community's NAQ:KTRA discussion board, with posts on KINTARA THERAPEUTICS INC share news, analysis and share sentiment. SAN DIEGO, Aug. 21, 2020 /PRNewswire/ -- Kintara Therapeutics, Inc. (formerly DelMar Pharmaceuticals, Inc.) ("Kintara" or the "Company") (Nasdaq: KTRA) announced today that it … S&P 500 0.84%. 3 months ago - Benzinga. (See KTRA stock analysis on TipRanks) DiaMedica Therapeutics . Utilizing its cutting-edge technologies, DiaMedica Therapeutics develops novel recombinant proteins to … KTRA, short/long term. What’s more, each boasts a massive upside potential.Kintara Therapeutics (KTRA)Working to meet the needs of patients who are failing or resistant to current treatment regimens, Kintara Therapeutics focuses on developing cutting-edge cancer therapies. I like yesterday's candle retesting the 0 fib level m testing the .38 level and closing above the .23 fib level. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). From Benzinga Mar 3, 2021. Kintara Therapeutics (KTRA) stock price, charts, trades & the US's most popular discussion forums. KTRA Stock Message Board for Investors. Kintara Therapeutics leadership team is committed to contributing to the battle against cancer by researching and developing novel cancer therapies that treat patients with significant unmet clinical need. 3 Replies | Report this Post. 24, 2021 Benzinga Newsdesk Tue, 23 Mar 2021 19:12:00 -0400. -11.46%. 3 “Strong Buy” Healthcare Stocks Under $5 That Could Go Boom. Trending now. This milestone will take place at the conclusion of the 2021 Russell Indexes' annual reconstitution, effective … KTRA 1.79 0.04 (2.29%) Post-Market 0.03 (1.68%) The stock's volume is currently 77.04 thousand, which is roughly 4.66% of its recent 30-day volume average of 1.66 million. Priced at around $2.50 with a EOY price target of $7, I could see this hitting $4 in the near term. SmartAce (93.02)Submitted July 27, 2020. Register for an account to get ideas, ask questions or join the conversation. DOW 0.75%. Kintara Therapeutics Inc. advanced stock charts by MarketWatch. vs. SP500 | 1 Year Performance. Kintara Therapeutics (KTRA) stock price, charts, trades & the US's most popular discussion forums. Dive deeper with interactive charts and top stories of KINTARA THERAPEUTICS, INC.. Stock Advisor launched in February of 2002. Since 2019, the healthcare sector has been bracing for the wild ride that would … S&P 500 0.16%. Kintara Therapeutics shares reverse split before market open on Wednesday, May 8th 2019. The 1-10 reverse split was announced on Tuesday, May 7th 2019. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 7th 2019. Benzinga's Biotech Small Cap Conference Schedule For Wednesday, Mar. Question. They are.

Spalding 5-inch Mini Basketball, Great Falls-dearborn Development, Thorpe Park New Ride Black Mirror, Pop Warner Disney 2021 Dates, Finke Desert Race Camping, Infertile Land Synonym,